SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $711,113 | +17.3% | 25,793 | +27.9% | 0.00% | – |
| Q2 2023 | $606,070 | -15.6% | 20,162 | +1.7% | 0.00% | – |
| Q1 2023 | $718,332 | +2.0% | 19,827 | +0.5% | 0.00% | – |
| Q4 2022 | $703,983 | +6.6% | 19,736 | +1.2% | 0.00% | – |
| Q3 2022 | $660,278 | +15.1% | 19,506 | -1.6% | 0.00% | – |
| Q2 2022 | $573,513 | -12.3% | 19,831 | -2.0% | 0.00% | – |
| Q1 2022 | $654,060 | -10.6% | 20,237 | -19.4% | 0.00% | – |
| Q4 2021 | $732,000 | +6.4% | 25,110 | -2.7% | 0.00% | -100.0% |
| Q3 2021 | $688,000 | -19.4% | 25,800 | -7.0% | 0.00% | 0.0% |
| Q2 2021 | $854,000 | +17.1% | 27,729 | -0.5% | 0.00% | 0.0% |
| Q1 2021 | $729,000 | -2.1% | 27,859 | -5.9% | 0.00% | 0.0% |
| Q4 2020 | $745,000 | +23.8% | 29,605 | +2.5% | 0.00% | 0.0% |
| Q3 2020 | $602,000 | -11.9% | 28,872 | -1.6% | 0.00% | 0.0% |
| Q2 2020 | $683,000 | +19.8% | 29,336 | -7.4% | 0.00% | 0.0% |
| Q1 2020 | $570,000 | -19.5% | 31,667 | +6.1% | 0.00% | 0.0% |
| Q4 2019 | $708,000 | -16.0% | 29,852 | -2.7% | 0.00% | 0.0% |
| Q3 2019 | $843,000 | -17.9% | 30,672 | -1.2% | 0.00% | 0.0% |
| Q2 2019 | $1,027,000 | -8.9% | 31,034 | -3.6% | 0.00% | 0.0% |
| Q1 2019 | $1,127,000 | +12.4% | 32,177 | +6.5% | 0.00% | 0.0% |
| Q4 2018 | $1,003,000 | -37.7% | 30,203 | -5.5% | 0.00% | -50.0% |
| Q3 2018 | $1,609,000 | -26.3% | 31,954 | -12.5% | 0.00% | 0.0% |
| Q2 2018 | $2,184,000 | +31.8% | 36,506 | +0.9% | 0.00% | 0.0% |
| Q1 2018 | $1,657,000 | +12.3% | 36,166 | -2.3% | 0.00% | 0.0% |
| Q4 2017 | $1,475,000 | +2.1% | 37,019 | +2.5% | 0.00% | 0.0% |
| Q3 2017 | $1,445,000 | -8.5% | 36,115 | -1.5% | 0.00% | 0.0% |
| Q2 2017 | $1,579,000 | +38.1% | 36,650 | +0.4% | 0.00% | +100.0% |
| Q1 2017 | $1,143,000 | +40.2% | 36,522 | +13.2% | 0.00% | 0.0% |
| Q4 2016 | $815,000 | +2.0% | 32,253 | -0.2% | 0.00% | 0.0% |
| Q3 2016 | $799,000 | +20.5% | 32,322 | -0.7% | 0.00% | 0.0% |
| Q2 2016 | $663,000 | +86.2% | 32,550 | +37.5% | 0.00% | – |
| Q1 2016 | $356,000 | +12.7% | 23,667 | +0.7% | 0.00% | – |
| Q4 2015 | $316,000 | -3.1% | 23,492 | +1.2% | 0.00% | – |
| Q3 2015 | $326,000 | -15.5% | 23,224 | +1.9% | 0.00% | – |
| Q2 2015 | $386,000 | +52.6% | 22,781 | +8.9% | 0.00% | – |
| Q1 2015 | $253,000 | +49.7% | 20,915 | +2.8% | 0.00% | – |
| Q4 2014 | $169,000 | -2.3% | 20,341 | +2.5% | 0.00% | – |
| Q3 2014 | $173,000 | -20.3% | 19,849 | +0.0% | 0.00% | – |
| Q2 2014 | $217,000 | +80.8% | 19,841 | +47.8% | 0.00% | – |
| Q1 2014 | $120,000 | +15.4% | 13,421 | -2.7% | 0.00% | – |
| Q4 2013 | $104,000 | +845.5% | 13,793 | +783.6% | 0.00% | – |
| Q3 2013 | $11,000 | -8.3% | 1,561 | -15.6% | 0.00% | – |
| Q2 2013 | $12,000 | – | 1,850 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |